跳至主要内容
临床试验/NCT02322710
NCT02322710已完成不适用

Multicentre, Randomized, Parallel Group, Non-inferiority, Open-label Study Aiming at Comparing the Healing Rates (With Blinded Assessment Based on Photographs) of TULLEGRAS M.S.® With URGOTUL® in the Treatment of Surgical Acute Wounds.

Mylan Inc.67 个研究点 分布在 1 个国家目标入组 208 人开始时间: 2014年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mylan Inc.
入组人数
208
试验地点
67
主要终点
Percentage of Patients With Complete Healing (100% of Epithelialization).

研究概览

简要总结

Evaluation of non-inferiority on healing rates of two dressings Urgotul and TulleGras MS in the treatment of surgical acute wounds.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female subject.
  • Aged 18 to 75 years
  • With a planned surgery:
  • Of abdominal location
  • Leading to an acute wound of a maximum total length ≤ 18 cm (corresponding to 2 investigational products)
  • Absence of clinical sign suggestive of worsened wound (assessed only at the randomization visit)
  • Followed-up in surgery department
  • Written and signed informed consent obtained
  • Affiliated to the French Social Security system or equivalent.

排除标准

  • Underlying pathology that may interfere with wound healing in the opinion of the Investigator (human immunodeficiency virus [HIV], cancer, immunodeficiency disease, generalized infection, systemic disease ...). The presence of low-risk prostate cancer according to the Amico classification (1) (PSA<10 ng/mL and Gleason's score < 6 and clinical grade T1c ou T2a) or a grade T1 (a or b) N0M0 renal cancer which requires surgery without adjuvant therapy (radiotherapy, chemotherapy, hormonal therapy...), in a patient whose general condition is preserved without significant comorbidity or signs of malnutrition are not considered as a non- inclusion criteria
  • Inadequately controlled diabetes (Glycosylated hemoglobin > 8%)
  • Hypo or hyperthyroidism
  • Intake of a systemic treatment with glucocorticoids or immunosuppressives
  • Known allergy to one of study dressings components
  • Participation in a clinical trial in the month prior to his/her inclusion in the study
  • Pregnancy or breastfeeding or of childbearing potential and saying not to use contraception.

结局指标

主要结局

Percentage of Patients With Complete Healing (100% of Epithelialization).

时间窗: Day 21

Using photographs,independent assessor blinded assessment.

次要结局

未报告次要终点

研究者

发起方
Mylan Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (67)

Loading locations...

相似试验

Comparison of Efficacy on Healing, and Safety of Two... | 临床试验